Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients - PubMed (original) (raw)
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients
M H Kollef et al. Chest. 1999 Feb.
Abstract
Study objective: To evaluate the relationship between inadequate antimicrobial treatment of infections (both community-acquired and nosocomial infections) and hospital mortality for patients requiring ICU admission.
Design: Prospective cohort study.
Setting: Barnes-Jewish Hospital, a university-affiliated urban teaching hospital.
Patients: Two thousand consecutive patients requiring admission to the medical or surgical ICU.
Interventions: Prospective patient surveillance and data collection.
Measurements and results: One hundred sixty-nine (8.5%) infected patients received inadequate antimicrobial treatment of their infections. This represented 25.8% of the 655 patients assessed to have either community-acquired or nosocomial infections. The occurrence of inadequate antimicrobial treatment of infection was most common among patients with nosocomial infections, which developed after treatment of a community-acquired infection (45.2%), followed by patients with nosocomial infections alone (34.3%) and patients with community-acquired infections alone (17.1%) (p < 0.001). Multiple logistic regression analysis, using only the cohort of infected patients (n = 655), demonstrated that the prior administration of antibiotics (adjusted odds ratio [OR], 3.39; 95% confidence interval [CI], 2.88 to 4.23; p < 0.001), presence of a bloodstream infection (adjusted OR, 1.88; 95% CI, 1.52 to 2.32; p = 0.003), increasing acute physiology and chronic health evaluation (APACHE) II scores (adjusted OR, 1.04; 95% CI, 1.03 to 1.05; p = 0.002), and decreasing patient age (adjusted OR, 1.01; 95% CI, 1.01 to 1.02; p = 0.012) were independently associated with the administration of inadequate antimicrobial treatment. The hospital mortality rate of infected patients receiving inadequate antimicrobial treatment (52.1%) was statistically greater than the hospital mortality rate of the remaining patients in the cohort (n = 1,831) without this risk factor (12.2%) (relative risk [RR], 4.26; 95% CI, 3.52 to 5.15; p < 0.001). Similarly, the infection-related mortality rate for infected patients receiving inadequate antimicrobial treatment (42.0%) was significantly greater than the infection-related mortality rate of infected patients receiving adequate antimicrobial treatment (17.7%) (RR, 2.37; 95% CI, 1.83 to 3.08; p < 0.001). Using a logistic regression model, inadequate antimicrobial treatment of infection was found to be the most important independent determinant of hospital mortality for the entire patient cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44; p < 0.001). The other identified independent determinants of hospital mortality included the number of acquired organ system derangements, use of vasopressor agents, the presence of an underlying malignancy, increasing APACHE II scores, increasing age, and having a nonsurgical diagnosis at the time of ICU admission.
Conclusions: Inadequate treatment of infections among patients requiring ICU admission appears to be an important determinant of hospital mortality. These data suggest that clinical efforts aimed at reducing the occurrence of inadequate antimicrobial treatment could improve the outcomes of critically ill patients. Additionally, prior antimicrobial therapy should be recognized as an important risk factor for the administration of inadequate antimicrobial treatment among ICU patients with clinically suspected infections.
Similar articles
- The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.
Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. Ibrahim EH, et al. Chest. 2000 Jul;118(1):146-55. doi: 10.1378/chest.118.1.146. Chest. 2000. PMID: 10893372 - Clinical predictors and outcomes for patients requiring tracheostomy in the intensive care unit.
Kollef MH, Ahrens TS, Shannon W. Kollef MH, et al. Crit Care Med. 1999 Sep;27(9):1714-20. doi: 10.1097/00003246-199909000-00003. Crit Care Med. 1999. PMID: 10507588 - Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices.
Kollef MH, Ward S, Sherman G, Prentice D, Schaiff R, Huey W, Fraser VJ. Kollef MH, et al. Crit Care Med. 2000 Oct;28(10):3456-64. doi: 10.1097/00003246-200010000-00014. Crit Care Med. 2000. PMID: 11057801 - [Evaluation of Infections in Intensive Care Units: A Multicentre Point-Prevalence Study].
Araç E, Kaya Ş, Parlak E, Büyüktuna SA, Baran Aİ, Akgül F, Gökler ME, Aksöz S, Sağmak Tartar A, Tekin R, Yıldız Y, Günay E. Araç E, et al. Mikrobiyol Bul. 2019 Oct;53(4):364-373. doi: 10.5578/mb.68665. Mikrobiyol Bul. 2019. PMID: 31709934 Review. Turkish. - Hospital-Acquired Infections in Critically Ill Patients With Cancer.
Battaglia CC, Hale K. Battaglia CC, et al. J Intensive Care Med. 2019 Jul;34(7):523-536. doi: 10.1177/0885066618788019. Epub 2018 Jul 16. J Intensive Care Med. 2019. PMID: 30012057 Review.
Cited by
- Appropriateness of Empiric Initiation of Meropenem in the Intensive Care Unit as Determined by Internal Medicine Residents.
Ishtiaq U, Acosta K, Akabusi C, Noble K, Gujadhur N, Cluzet V. Ishtiaq U, et al. Antimicrob Steward Healthc Epidemiol. 2024 Oct 24;4(1):e185. doi: 10.1017/ash.2024.410. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39465212 Free PMC article. - Optimization of antibiotic use in the intensive care unit: how we do it.
Moniz P, Fustiga J, Herculano MM, Póvoa P. Moniz P, et al. Crit Care Sci. 2024 Oct 21;36:e20240017en. doi: 10.62675/2965-2774.20240017-en. eCollection 2024. Crit Care Sci. 2024. PMID: 39442132 Free PMC article. No abstract available. - Retrospective validation study of a machine learning-based software for empirical and organism-targeted antibiotic therapy selection.
Tejeda MI, Fernández J, Valledor P, Almirall C, Barberán J, Romero-Brufau S. Tejeda MI, et al. Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0077724. doi: 10.1128/aac.00777-24. Epub 2024 Aug 28. Antimicrob Agents Chemother. 2024. PMID: 39194206 Free PMC article. - Updates on Antibiotic Regimens in Acute Cholecystitis.
Fico V, La Greca A, Tropeano G, Di Grezia M, Chiarello MM, Brisinda G, Sganga G. Fico V, et al. Medicina (Kaunas). 2024 Jun 25;60(7):1040. doi: 10.3390/medicina60071040. Medicina (Kaunas). 2024. PMID: 39064469 Free PMC article. Review. - Changes of PK/PD of Meropenem in patients with abdominal septic shock and exploration of clinical rational administration plan: a prospective exploratory study.
Wang Y, Li H, Wang D, Li Y, Shen Y, Fu Y, Li Y, Gao M, Zhang D. Wang Y, et al. Sci Rep. 2024 May 3;14(1):10173. doi: 10.1038/s41598-024-60909-7. Sci Rep. 2024. PMID: 38702351 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources